Excessive inflammasome activation results in abundant IL-1β release and subsequent systemic hyperinflammation, contributing to pulmonary damage, and potentially to endotheliopathy and coagulopathy, hence resulting in widespread organ damage as observed in severe COVID-19.12 This evidence concerns the gene IL1B and COVID-19.